Law360 quoted Peter Goss in an article on recent efforts by a Chinese drywall manufacturer, Taishan Gypsum Co. Ltd., to resolve a $2.7 million default judgment and sanctions order against the company. Goss noted that “It took some extreme measures to bring Taishan to [the] table, but it shows that if you’re going to be successful suing a Chinese company [in the U.S.], this is what it may take.” The article is available to Law360 subscribers here .
Mr. Goss focuses his national practice on pharmaceutical and medical device product liability litigation and toxic torts. He has represented global pharmaceutical, medical technology, and chemical firms in hundreds of cases. Mr. Goss, who has won several published Daubert decisions, often serves as “science counsel” in life sciences litigation. He collaborates with leading experts to present complex medical and scientific evidence, both in dispositive motions and at trial. He is a frequent commentator on scientific evidence, products liability, and legal developments of interest to FDA-regulated industries.
Blackwell Burke P.A., a litigation and trial boutique in Minneapolis, Minnesota, serves as national trial and litigation counsel for numerous Fortune 500 companies. The firm has extensive experience in class action defense, commercial litigation, food industry defense, labor and employment, and products liability. The firm has represented corporate clients in state and federal courts throughout the country and in several foreign jurisdictions.
For more information about Blackwell Burke P.A. or Mr. Goss, please contact Kandy Branch at 612-343-3235 or [email protected].